CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $25.68 million. The enterprise value is $20.07 million.

Market Cap	25.68M
Enterprise Value	20.07M

Important Dates

The last earnings date was Wednesday, November 26, 2025, before market open.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

CLGN has 12.78 million shares outstanding. The number of shares has increased by 3.64% in one year.

Current Share Class	12.78M
Shares Outstanding	12.78M
Shares Change (YoY)	+3.64%
Shares Change (QoQ)	+7.44%
Owned by Insiders (%)	45.60%
Owned by Institutions (%)	11.87%
Float	6.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.64
Forward PS	2.02
PB Ratio	2.76
P/TBV Ratio	2.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.32.

Current Ratio	3.66
Quick Ratio	3.34
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -92.74% and return on invested capital (ROIC) is -47.46%.

Return on Equity (ROE)	-92.74%
Return on Assets (ROA)	-42.11%
Return on Invested Capital (ROIC)	-47.46%
Return on Capital Employed (ROCE)	-107.42%
Revenue Per Employee	$43,421
Profits Per Employee	-$213,333
Employee Count	57
Asset Turnover	0.14
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.47% in the last 52 weeks. The beta is 0.67, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-50.47%
50-Day Moving Average	2.26
200-Day Moving Average	2.35
Relative Strength Index (RSI)	40.47
Average Volume (20 Days)	19,443

Short Selling Information

Short Interest	121,057
Short Previous Month	125,645
Short % of Shares Out	1.35%
Short % of Float	n/a
Short Ratio (days to cover)	3.75

Income Statement

In the last 12 months, CLGN had revenue of $2.48 million and -$12.16 million in losses. Loss per share was -$1.02.

Revenue	2.48M
Gross Profit	1.56M
Operating Income	-12.31M
Pretax Income	-12.16M
Net Income	-12.16M
EBITDA	-11.37M
EBIT	-12.31M
Loss Per Share	-$1.02

Full Income Statement

Balance Sheet

The company has $8.55 million in cash and $2.94 million in debt, giving a net cash position of $5.61 million or $0.44 per share.

Cash & Cash Equivalents	8.55M
Total Debt	2.94M
Net Cash	5.61M
Net Cash Per Share	$0.44
Equity (Book Value)	9.31M
Book Value Per Share	0.73
Working Capital	6.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.95 million and capital expenditures -$72,000, giving a free cash flow of -$10.02 million.

Operating Cash Flow	-9.95M
Capital Expenditures	-72,000
Free Cash Flow	-10.02M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross Margin	63.03%
Operating Margin	-497.25%
Pretax Margin	-491.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.64%
Shareholder Yield	-3.64%
Earnings Yield	-47.35%
FCF Yield	-39.02%

Analyst Forecast

The average price target for CLGN is $11.50, which is 472.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	472.14%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 1:1.5.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	1:1.5

Scores

CLGN has an Altman Z-Score of -9.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.79
Piotroski F-Score	3